Zdrowie i gospodarka · 10/06/2016
FDA Releases Guidance on Compounding with Bulk Drug Substances
The FDA has announced a new guidance for industry regarding compounding with bulk drug substances, outlining the agency's interim policy on outsourcing facilities that compound human drug products using bulk drug substances while the FDA develops its list of approved substances.